• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝外铁负荷与血色素沉着症发生晚期肝纤维化的倾向相关。

Extrahepatic Iron Loading Associates With the Propensity to Develop Advanced Hepatic Fibrosis in Hemochromatosis.

作者信息

Olynyk John K, St Pierre Timothy G, Chen James, Frazer David M, Ramm Louise E, Ramm Grant A

机构信息

Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.

Department of Gastroenterology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

出版信息

Gastro Hep Adv. 2024 Jan 24;3(4):454-460. doi: 10.1016/j.gastha.2024.01.011. eCollection 2024.

DOI:10.1016/j.gastha.2024.01.011
PMID:39131712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11307999/
Abstract

BACKGROUND AND AIMS

Hemostatic iron regulator-hemochromatosis can result in progressive iron-loading and advanced hepatic fibrosis in some individuals. We studied total body and hepatic iron loading to determine whether the distribution of iron-loading influences the risk of advanced fibrosis.

METHODS

One hundred thirty-eight men and 66 women with hemochromatosis who underwent liver biopsy for staging of hepatic fibrosis had evaluation of hepatic iron concentration (HIC), hepatic iron index (HIC/age), total body iron stores (mobilizable iron), and mobilizable iron/HIC ratio (a marker of total body iron relative to hepatic iron). The potential impact of liver volume on mobilizable iron stores was assessed using magnetic resonance imaging in a separate cohort of 19 newly diagnosed individuals with hemochromatosis.

RESULTS

Of 204 biopsied subjects, 41 had advanced fibrosis and exhibited 60% greater accumulation of mobilizable iron relative to HIC (mean 0.070 ± 0.008 g Fe/[μmol Fe/g]) compared with 163 subjects with low-grade fibrosis (mean 0.044 ± 0.002 g Fe/[μmol Fe/g], < .0001). Linear regression modeling confirmed a discrete advanced hepatic fibrosis phenotype associated with greater mobilizable iron stores relative to HIC. The ratios of the upper to lower 95% limits of the distributions of liver volumes and the mobilizable iron/HIC ratios were 2.7 (95% confidence interval 2.3-3.0) and 9.7 (95% confidence interval 8.0-11.7), respectively, indicating that the distribution of liver volumes is not sufficiently wide to explain the variability in mobilizable iron/HIC ratios, suggesting that significant extrahepatic iron loading is present in those with advanced hepatic fibrosis.

CONCLUSION

Advanced hepatic fibrosis develops in hemostatic iron regulator-hemochromatosis individuals who also have excessive extrahepatic mobilizable iron stores.

摘要

背景与目的

止血性铁调节蛋白 - 血色素沉着症在某些个体中可导致进行性铁负荷增加和晚期肝纤维化。我们研究了全身和肝脏的铁负荷情况,以确定铁负荷的分布是否会影响晚期纤维化的风险。

方法

138名男性和66名患有血色素沉着症且接受肝活检以进行肝纤维化分期的女性,对其进行了肝铁浓度(HIC)、肝铁指数(HIC/年龄)、全身铁储存(可动员铁)以及可动员铁/HIC比值(全身铁相对于肝脏铁的标志物)的评估。在另一组19名新诊断的血色素沉着症个体中,使用磁共振成像评估肝脏体积对可动员铁储存的潜在影响。

结果

在204名接受活检的受试者中,41名患有晚期纤维化,与163名低级别纤维化受试者相比,其可动员铁相对于HIC的积累量高60%(平均0.070±0.008 g Fe/[μmol Fe/g] 对比平均0.044±0.002 g Fe/[μmol Fe/g],P <.0001)。线性回归模型证实了一种与相对于HIC更高的可动员铁储存相关的离散晚期肝纤维化表型。肝脏体积分布的95%上限与下限之比以及可动员铁/HIC比值分布的95%上限与下限之比分别为2.7(95%置信区间2.3 - 3.0)和9.7(95%置信区间8.0 - 11.7),这表明肝脏体积分布不够宽泛,无法解释可动员铁/HIC比值的变异性,提示晚期肝纤维化患者存在显著的肝外铁负荷。

结论

在止血性铁调节蛋白 - 血色素沉着症个体中,晚期肝纤维化的发生与肝外可动员铁储存过多有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717e/11307999/c85c003dfa36/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717e/11307999/0428d22a5dc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717e/11307999/c85c003dfa36/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717e/11307999/0428d22a5dc7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717e/11307999/c85c003dfa36/gr2.jpg

相似文献

1
Extrahepatic Iron Loading Associates With the Propensity to Develop Advanced Hepatic Fibrosis in Hemochromatosis.肝外铁负荷与血色素沉着症发生晚期肝纤维化的倾向相关。
Gastro Hep Adv. 2024 Jan 24;3(4):454-460. doi: 10.1016/j.gastha.2024.01.011. eCollection 2024.
2
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.肝铁或全身铁负荷在 HFE 血色病中评估晚期肝纤维化的效用。
Sci Rep. 2019 Dec 27;9(1):20234. doi: 10.1038/s41598-019-56732-0.
3
Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.HFE基因C282Y纯合子的血色素沉着症患者与其他HFE基因型患者之间肝脏表型的差异。
J Clin Gastroenterol. 2009 Jul;43(6):569-73. doi: 10.1097/MCG.0b013e3181919a33.
4
Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.遗传性血色素沉着症的基因型与表型之间的相关性:61例分析。
Blood Cells Mol Dis. 1997 Aug;23(2):314-20. doi: 10.1006/bcmd.1997.0148.
5
Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus.遗传性血色素沉着症的临床合并症和肝纤维化:糖尿病的作用。
Hepatology. 2012 Sep;56(3):904-11. doi: 10.1002/hep.25720. Epub 2012 Jun 19.
6
The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.HFE 血色病中,祖源单体型标记 HLA-A3 和 B7 并不影响发生晚期肝纤维化或肝硬化的可能性。
Sci Rep. 2023 May 13;13(1):7775. doi: 10.1038/s41598-023-35028-4.
7
Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.肝脏铁暴露的持续时间会增加遗传性血色素沉着症发生显著纤维化的风险:磁共振成像的新作用
Am J Gastroenterol. 2005 Apr;100(4):837-41. doi: 10.1111/j.1572-0241.2005.41287.x.
8
Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.铁调素基因突变所致血色病患者静脉放血前后血清标志物指标对肝纤维化分期的价值。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1459-1468.e5. doi: 10.1016/j.cgh.2020.07.052. Epub 2020 Aug 1.
9
Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.遗传性血色素沉着症中的肝脏铁浓度不会饱和,也不能准确预测放血治疗的需求量。
Am J Gastroenterol. 1998 Mar;93(3):346-50. doi: 10.1111/j.1572-0241.1998.00346.x.
10
Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.血清铁蛋白浓度比肝铁浓度更能预测人类 HFE 血色病中的肝纤维化。
Liver Int. 2017 Sep;37(9):1382-1388. doi: 10.1111/liv.13395. Epub 2017 Mar 17.

引用本文的文献

1
Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption.利用可动员铁储存和酒精摄入量对HFE血色素沉着症患者的肝硬化和肝细胞癌进行风险评估
Sci Rep. 2025 May 8;15(1):16011. doi: 10.1038/s41598-025-99672-8.

本文引用的文献

1
Haemochromatosis.血色病。
Lancet. 2023 May 27;401(10390):1811-1821. doi: 10.1016/S0140-6736(23)00287-8. Epub 2023 Apr 27.
2
Hemochromatosis.血色素沉着症
N Engl J Med. 2022 Dec 8;387(23):2159-2170. doi: 10.1056/NEJMra2119758.
3
Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.血色病 HFE p.C282Y 纯合子与肝恶性肿瘤的关联。
JAMA. 2020 Nov 24;324(20):2048-2057. doi: 10.1001/jama.2020.21566.
4
Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.肝铁或全身铁负荷在 HFE 血色病中评估晚期肝纤维化的效用。
Sci Rep. 2019 Dec 27;9(1):20234. doi: 10.1038/s41598-019-56732-0.
5
Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.与遗传性血色素沉着症遗传变异相关的常见病症:英国生物库队列研究。
BMJ. 2019 Jan 16;364:k5222. doi: 10.1136/bmj.k5222.
6
Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.血清铁蛋白浓度比肝铁浓度更能预测人类 HFE 血色病中的肝纤维化。
Liver Int. 2017 Sep;37(9):1382-1388. doi: 10.1111/liv.13395. Epub 2017 Mar 17.
7
Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt.肝肽素通过抑制铁蛋白介导的 Akt 调节来抑制肝星状细胞中 Smad3 的磷酸化。
Nat Commun. 2016 Dec 22;7:13817. doi: 10.1038/ncomms13817.
8
Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration.自旋密度投影辅助R2-MRI用于无创测量肝脏铁浓度的多中心验证
Magn Reson Med. 2014 Jun;71(6):2215-23. doi: 10.1002/mrm.24854. Epub 2013 Jul 2.
9
Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus.遗传性血色素沉着症的临床合并症和肝纤维化:糖尿病的作用。
Hepatology. 2012 Sep;56(3):904-11. doi: 10.1002/hep.25720. Epub 2012 Jun 19.
10
Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.铁调素蛋白和转铁蛋白受体 2 的破坏导致小鼠铁诱导的肝损伤。
Hepatology. 2012 Aug;56(2):585-93. doi: 10.1002/hep.25689. Epub 2012 Jun 11.